Saffron Formulations Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
- Paid Up Capital ₹ 7.50 M
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.95 Cr
- Satisfied Charges ₹ 4.01 Cr
- Revenue Growth 30.84%
- Profit Growth 122.18%
- Ebitda 51.08%
- Net Worth 32.14%
- Total Assets 0.68%
About Saffron Formulations
Saffron Formulations Private Limited (SFPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 21 May 2015 (Nine years and eight months 27 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹8.95 Cr. The company has closed loans amounting to ₹4.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Amit Singh and Hiren Patel serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74120GJ2015PTC083277
-
Company No.
083277
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 May 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Saffron Formulations Private Limited offer?
Saffron Formulations Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs, Respiratory System Drugs, Anti Asthma Drug, Nutraceuticals & Dietary Supplements, Vitamin & Multivitamin Injections, Pharma Ingredients & Raw Materials, Blood System and Cardiovascular API, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup.
Who are the key members and board of directors at Saffron Formulations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Singh
|
Director | 21-May-2015 | Current |
|
Hiren Patel
|
Director | 21-May-2015 | Current |
Financial Performance of Saffron Formulations.
Saffron Formulations Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 30.84% increase. The company also saw a substantial improvement in profitability, with a 122.18% increase in profit. The company's net worth Soared by an impressive increase of 32.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saffron Formulations?
In 2024, Saffron Formulations had a promoter holding of 98.00% and a public holding of 2.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Saffron Therapeutics Private LimitedAmit Singh and Hiren Patel are mutual person
Charges (Loans)
₹89.47 M
₹40.11 M
Charges Breakdown by Lending Institutions
- Others : 8.45 Cr
- Hdfc Bank Limited : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Nov 2024 | Others | ₹6.00 Cr | Open |
| 28 Nov 2022 | Hdfc Bank Limited | ₹5.00 M | Open |
| 28 Jul 2022 | Others | ₹2.45 Cr | Open |
| 23 Sep 2020 | Others | ₹1.96 Cr | Satisfied |
| 22 Oct 2018 | State Bank Of India | ₹2.05 Cr | Satisfied |
How Many Employees Work at Saffron Formulations?
Saffron Formulations has a workforce of 529 employees as of Jan 16, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saffron Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saffron Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.